Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Prospective, Randomized, Double-blind, Placebo Controlled, Multi-national Study of Therapeutic Anticoagulation Strategy for Acute Chest Syndrome in Adults

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02580773
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:58.894467+00:00
Published At
2024-02-09T00:00:00+00:00
Record Updated At
2024-02-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Anemia", "Sickle Cell", "Acute Chest Syndrome", "Low-Molecular-Weight Heparin"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-02-09"
protocolSection.identificationModule.nctId
"NCT02580773"
protocolSection.identificationModule.officialTitle
"A Prospective, Randomized, Double-blind, Placebo Controlled, Multi-national Study of Therapeutic Anticoagulation Strategy for Acute Chest Syndrome in Adults"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Anemia (protocolSection.conditionsModule.conditions)
  • Sickle Cell (protocolSection.conditionsModule.conditions)
  • Acute Chest Syndrome (protocolSection.conditionsModule.conditions)
  • Low-Molecular-Weight Heparin (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.